PureTech News

Press releases
Press Releases - 2024-02-27
Other
PureTech to Present at Two Upcoming Investor Conferences
Press Releases - 2024-02-27
Other
Akili
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in Japan
Press Releases - 2024-01-03
Other
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
Press Releases - 2023-12-22
Karuna
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
Press Releases - 2023-12-20
Wholly Owned Pipeline - LYT-100
Other
PureTech Year End Update and Outlook for 2024
Press Releases - 2023-12-07
Gallop Oncology – LYT-200
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
Press Releases - 2023-11-29
Other
Karuna
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Press Releases - 2023-11-17
Other
Karuna
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
Press Releases - 2023-11-14
Seaport
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
Press Releases - 2023-10-17
Other
PureTech to Present at Two Upcoming Investor Conferences
Displaying 21 - 30 of 172

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH